An up-to-date concise review: NEJM 2014; 371: 836-45.

A few key points:

• “Despite the lack of high-quality evidence to support the practice, medical societies currently recommend endoscopic screening for Barrett’s esophagus in patients with chronic GERD symptoms who have at least one additional risk factor…such as age of 50 years or older, male sex, white race, hiatal hernia, elevated body-mass index…or tobacco use.”
• If nondysplastic Barrett’s is identified, then followup endoscopy is recommended at intervals of 3 to 5 years.  Though, authors note that surveillance has not been proven to reduce death from esophageal cancer.
• The authors recommend PPIs even in asymptomatic Barrett’s esophagus.

One other reference: Gastroenterol 2014; 147: 314-23.  “Statin Use is Assciated with a Decreased Risk of Barrett’s”

Related blog posts:

• RFA doesn’t always work for Barrett’s | gutsandgrowth
• Barrett’s Esophagus –refer to cardiology? | gutsandgrowth